Cobicistat, Darunavir

Prezcobix Flim-Coated Tablets

膜衣錠TaiwanAuthorisedAuthorised 17 Nov 2017

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Cobicistat, Darunavir

Prezcobix Flim-Coated Tablets

膜衣錠TaiwanAuthorisedAuthorised 17 Nov 2017

Ask Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Rezolsta 800 MG/150 MG Comprimidos Recubiertos con PeliculaSpain · 867,28 mg + 150 mg · comprimido recubierto con película · Janssen-Cilag International N.V

RezolstaItaly · Compressa rivestita con film · Janssen-Cilag International N.V.

Rezolsta 600 mg/90 mg dispergeerbare tablettenNetherlands · Dispergeerbare tablet · Janssen-Cilag International NV

REZOLSTA 675 mg/150 mg filmomhulde tablettenNetherlands · Filmomhulde tablet · Janssen-Cilag International NV

REZOLSTA 800 mg/150 mg filmomhulde tablettenNetherlands · Filmomhulde tablet · Janssen-Cilag International NV

Rezolsta®Serbia · 800mg+150mg · film tableta · PredstavniŠTvo Janssen-Cilag KFT Beograd

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Taiwan Food and Drug Administration

TFDA, dataset 9122, Government Open Data Licence 1.0; source update and retrieval dates

Licence: Taiwan Government Open Data Licence 1.0 · Added 7 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Cobicistat, Darunavir
Dosage form: 膜衣錠
Register: Taiwan (TFDA)
Status: Authorised
Authorised: 17 Nov 2017
Registration: 衛部藥輸字第027263號
Marketing authorisation holder: 嬌生股份有限公司
Procedure: 製　劑